Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $40,376 - $52,575
6,630 Added 39.18%
23,553 $147,000
Q3 2022

Nov 14, 2022

SELL
$4.58 - $9.21 $2,312 - $4,651
-505 Reduced 2.9%
16,923 $117,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $23.63 $40,729 - $136,321
5,769 Added 49.48%
17,428 $146,000
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $123,400 - $158,764
-5,713 Reduced 32.89%
11,659 $266,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $158,125 - $199,443
6,875 Added 65.49%
17,372 $480,000
Q3 2021

Nov 15, 2021

BUY
$25.04 - $30.06 $50,555 - $60,691
2,019 Added 23.81%
10,497 $292,000
Q2 2021

Aug 13, 2021

BUY
$27.43 - $32.7 $232,551 - $277,230
8,478 New
8,478 $249,000
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $220,356 - $303,980
-14,393 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $106,957 - $144,694
-7,188 Reduced 33.31%
14,393 $224,000
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $287,243 - $442,626
21,581 New
21,581 $395,000
Q1 2020

Jun 02, 2020

SELL
$12.98 - $30.25 $162,847 - $379,516
-12,546 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $10,049 - $16,965
532 Added 4.43%
12,546 $375,000
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $76,441 - $93,941
-3,661 Reduced 23.36%
12,014 $263,000
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $158,906 - $204,828
-7,744 Reduced 33.07%
15,675 $395,000
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $76,671 - $99,639
-3,790 Reduced 13.93%
23,419 $578,000
Q4 2018

Feb 14, 2019

SELL
$17.64 - $28.32 $48,298 - $77,540
-2,738 Reduced 9.14%
27,209 $503,000
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $618,106 - $768,739
29,947 New
29,947 $769,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.